Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 503

1.

Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.

Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M.

Clin Chem. 2001 Nov;47(11):2023-8.

2.

Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.

Korponay-Szabó IR, Vecsei Z, Király R, Dahlbom I, Chirdo F, Nemes E, Fésüs L, Mäki M.

J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):253-61. doi: 10.1097/MPG.0b013e31815ee555.

PMID:
18376241
3.

Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.

Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):55-60. doi: 10.1097/MPG.0b013e3182145511.

PMID:
21694536
4.

Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I.

J Clin Lab Anal. 2009;23(3):165-71. doi: 10.1002/jcla.20313.

PMID:
19455636
5.

New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deamidated gliadin.

Prause C, Richter T, Koletzko S, Uhlig HH, Hauer AC, Stern M, Zimmer KP, Laass MW, Probst C, Schlumberger W, Mothes T.

Ann N Y Acad Sci. 2009 Sep;1173:28-35. doi: 10.1111/j.1749-6632.2009.04638.x.

PMID:
19758128
6.
7.

Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.

Vermeersch P, Geboes K, Mariën G, Hoffman I, Hiele M, Bossuyt X.

Clin Chim Acta. 2010 Jul 4;411(13-14):931-5. doi: 10.1016/j.cca.2010.02.060. Epub 2010 Feb 19.

PMID:
20171961
8.

Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.

Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE.

Clin Exp Immunol. 2007 Nov;150(2):285-93. Epub 2007 Sep 4.

9.
10.

IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.

Villalta D, Tonutti E, Prause C, Koletzko S, Uhlig HH, Vermeersch P, Bossuyt X, Stern M, Laass MW, Ellis JH, Ciclitira PJ, Richter T, Daehnrich C, Schlumberger W, Mothes T.

Clin Chem. 2010 Mar;56(3):464-8. doi: 10.1373/clinchem.2009.128132. Epub 2009 Dec 18.

11.

[Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays].

Lutteri L, Sagot C, Chapelle JP.

Ann Biol Clin (Paris). 2010 Mar-Apr;68(2):149-56. doi: 10.1684/abc.2010.0398. French.

12.

A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.

Dørum S, Qiao SW, Sollid LM, Fleckenstein B.

J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n.

PMID:
19239248
13.
14.

Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.

Van Meensel B, Hiele M, Hoffman I, Vermeire S, Rutgeerts P, Geboes K, Bossuyt X.

Clin Chem. 2004 Nov;50(11):2125-35. Epub 2004 Sep 23.

15.

Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.

Basso D, Guariso G, Fogar P, Meneghel A, Zambon CF, Navaglia F, Greco E, Schiavon S, Rugge M, Plebani M.

Clin Chem. 2009 Jan;55(1):150-7. doi: 10.1373/clinchem.2008.110395. Epub 2008 Nov 6.

16.

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN.

J Exp Med. 2000 Feb 21;191(4):603-12.

17.

Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.

Mankaï A, Sakly W, Landolsi H, Gueddah L, Sriha B, Ayadi A, Sfar MT, Skandrani K, Harbi A, Essoussi AS, Korbi S, Fabien N, Jeddi M, Ghedira I.

Pathol Biol (Paris). 2005 May;53(4):204-9.

PMID:
15850953
18.

Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.

Niveloni S, Sugai E, Cabanne A, Vazquez H, Argonz J, Smecuol E, Moreno ML, Nachman F, Mazure R, Kogan Z, Gomez JC, Mauriño E, Bai JC.

Clin Chem. 2007 Dec;53(12):2186-92. Epub 2007 Sep 27.

19.

Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.

Fleckenstein B, Molberg Ø, Qiao SW, Schmid DG, von der Mülbe F, Elgstøen K, Jung G, Sollid LM.

J Biol Chem. 2002 Sep 13;277(37):34109-16. Epub 2002 Jul 1.

20.

Synthetic peptides reproducing tissue transglutaminase-gliadin complex neo-epitopes as probes for antibody detection in celiac disease patients' sera.

Di Pisa M, Pascarella S, Scrima M, Sabatino G, Real-Fernández F, Chelli M, Renzi D, Calabrò A, D'Ursi AM, Papini AM, Rovero P.

J Med Chem. 2015 Feb 12;58(3):1390-9. doi: 10.1021/jm5017126. Epub 2015 Jan 26.

PMID:
25588142

Supplemental Content

Support Center